The measurement of glycated hemoglobin (HbA1c) is the most common test to monitor glycemic control in patient with diabetes. However, there are some limitations for short-term variations in blood glucose change and incorrectness in patients with abnor...
The measurement of glycated hemoglobin (HbA1c) is the most common test to monitor glycemic control in patient with diabetes. However, there are some limitations for short-term variations in blood glucose change and incorrectness in patients with abnormal hemoglobin production. Glycated albumin (GA) is more sensitive indicator of short-term glycemic change than HbA1c and many studies have been reported recently according to develop measurement method. As assistant of HbA1c, GA can be a valuable method enough, and in advance, it could be the first method instead of HbA1c in some diseases, such as end-stage renal disease with hemodialysis. But most of all, it is necessary to standardize the measurement method of GA and to decide normal reference range. (Korean Clinical Diabetes J 11:35-39, 2010)